SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-032007
Filing Date
2023-04-24
Accepted
2023-04-24 16:00:27
Documents
13
Period of Report
2023-04-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea177365-8k_inmunebio.htm   iXBRL 8-K 25034
2 PRESS RELEASE DATED APRIL 24, 2023 ea177365ex99-1_inmunebio.htm EX-99.1 11339
  Complete submission text file 0001213900-23-032007.txt   214907

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inmb-20230424.xsd EX-101.SCH 2962
4 XBRL LABEL FILE inmb-20230424_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inmb-20230424_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT ea177365-8k_inmunebio_htm.xml XML 3709
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 23839971
SIC: 2836 Biological Products, (No Diagnostic Substances)